• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/11/21 8:39:52 AM ET
    $VSPR
    Business Services
    Finance
    Get the next $VSPR alert in real time by email
    SC 13G/A 1 p21-0534sc13ga.htm VESPER HEALTHCARE ACQUISITION CORP.

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G/A
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*
     

    Vesper Healthcare Acquisition Corp.

    (Name of Issuer)
     

    Class A Common Stock, $0.0001 par value per share

    (Title of Class of Securities)
     

    92538T104

    (CUSIP Number)
     

    December 31, 2020

    (Date of Event Which Requires Filing of This Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ¨ Rule 13d-1(b)
    ý Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 8 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 92538T104

    13G/APage 2 of 8 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Empyrean Capital Overseas Master Fund, Ltd.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Cayman Islands

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    1,781,152

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    1,781,152

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,781,152

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    3.9%

    12

    TYPE OF REPORTING PERSON

    CO

             

     

     

    CUSIP No. 92538T104

    13G/APage 3 of 8 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Empyrean Capital Partners, LP

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    1,781,152

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    1,781,152

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,781,152

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    3.9%

    12

    TYPE OF REPORTING PERSON

    PN

             

     

     

     

    CUSIP No. 92538T104

    13G/APage 4 of 8 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Amos Meron

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ý

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    1,781,152

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    1,781,152

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,781,152

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    3.9%

    12

    TYPE OF REPORTING PERSON

    IN

             

     

     

     

    CUSIP No. 92538T104

    13G/APage 5 of 8 Pages

     

    Item 1(a). NAME OF ISSUER.
       
      The name of the issuer is Vesper Healthcare Acquisition Corp. (the "Issuer").

     

    Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
       
      The Issuer's principal executive offices are located at 1819 West Avenue, Bay 2, Miami Beach, FL 33139.

     

    Item 2(a). NAME OF PERSON FILING:

     

      This statement is filed by:

     

      (i) Empyrean Capital Overseas Master Fund, Ltd. ("ECOMF"), a Cayman Islands exempted company, with respect to the Class A Common Stock (as defined in Item 2(d)) directly held by it;
       
      (ii) Empyrean Capital Partners, LP ("ECP"), a Delaware limited partnership, which serves as investment manager to ECOMF with respect to the Class A Common Stock directly held by ECOMF;
       
      (iii) Mr. Amos Meron, who serves as the managing member of Empyrean Capital, LLC, the general partner of ECP, with respect to the Class A Common Stock directly held by ECOMF.

     

      The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."  Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.
       
      The foregoing should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of Class A Common Stock owned by another Reporting Person.

     

    Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

     

      The address of the business office of each of the Reporting Persons is c/o Empyrean Capital Partners, LP, 10250 Constellation Boulevard, Suite 2950, Los Angeles, CA 90067.

     

    Item 2(c). CITIZENSHIP:

     

      ECOMF - a Cayman Island exempted company
      ECP - a Delaware limited partnership
      Amos Meron - United States

     

     

    CUSIP No. 92538T104

    13G/APage 6 of 8 Pages

     

    Item 2(d). TITLE OF CLASS OF SECURITIES:
       
      Class A common stock, $0.0001 par value per share (the "Class A Common Stock")

     

    Item 2(e). CUSIP NUMBER:
       
      92538T104

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) ¨ Investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
      (f) ¨

    Employee benefit plan or endowment fund in accordance with

    § 240.13d-1(b)(1)(ii)(F);

     

      (g) ¨

    Parent holding company or control person in accordance with

    § 240.13d-1(b)(1)(ii)(G);

      (h) ¨

    Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i) ¨

    Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

      (j) ¨ Non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

     

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please

    specify the type of institution:                                                                                            

     

     

    CUSIP No. 92538T104

    13G/APage 7 of 8 Pages

     

    Item 4. OWNERSHIP.

     

        The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person.
         
        The percentages used herein are calculated based upon 46,000,000 Common Shares issued and outstanding as of November 16, 2020, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020, filed with the Securities and Exchange Commission on November 16, 2020.

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
       
      If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following: x

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
       
      Not applicable.

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
       
      Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
       
      Not applicable.

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP.
       
      Not applicable.

     

    Item 10. CERTIFICATION.

     

      Each of the Reporting Persons hereby makes the following certification:
       
      By signing below the Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

    CUSIP No. 92538T104

    13G/APage 8 of 8 Pages

    SIGNATURES

    After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

    DATED: February 11, 2021

     

      empyrean capital partners, lp
       
      By: /s/ C. Martin Meekins
      Name:  C. Martin Meekins
      Title:  Chief Operating Officer
       
      Empyrean Capital Overseas MASTER Fund, Ltd.
      By: Empyrean Capital Partners, LP,
      its Investment Manager
       
      By: /s/ C. Martin Meekins
      Name:  C. Martin Meekins
      Title:  Chief Operating Officer
       
      /s/ Amos Meron
      AMOS MERON

     

    Get the next $VSPR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSPR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VSPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Linden and DW Healthcare Partners Complete HydraFacial's Public Offering via SPAC Merger

    CHICAGO and PARK CITY, Utah, May 5, 2021 /PRNewswire/ -- Linden Capital Partners ("Linden") and DW Healthcare Partners IV, LP ("DW Healthcare Partners"), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of Edge Systems, LLC ("HydraFacial"), a category-creating beauty health company, with Vesper Healthcare Acquisition Corp. (NASDAQ:VSPR) ("Vesper" or "Vesper Healthcare"). Vesper is a special purpose acquisition company ("SPAC") led by former Allergan CEO Brent Saunders. As a result of the transaction, the combined company, now known as The Beauty Health Company ("BeautyHealth" or the "Company"), is expected to trade on the Na

    5/5/21 7:30:00 AM ET
    $VSPR
    Business Services
    Finance

    HydraFacial Announces Record First Quarter Fiscal 2021 Preliminary Net Sales

    First Quarter 2021 Preliminary Financial Highlights: Q1 net sales of $47 million compared to $33 million in Q1 2020 and $35 million in Q1 2019 Q1 net sales in the Americas region of $31 million, or 66% of total net sales, compared to $24 million in Q1 2020 and $27 million in Q1 2019 Q1 net sales in the EMEA and APAC regions of $16 million, or 34% of total sales, compared to $9 million in Q1 2020 and $8 million in Q1 2019 The HydraFacial® Company ("HydraFacial," or the "Company"), an experiential category-creating beauty health company, today announced preliminary net sales for the quarter ended March 31, 2021. The Company has not yet completed the quarter-end review and expects to r

    4/21/21 6:45:00 AM ET
    $VSPR
    Business Services
    Finance

    HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales

    MIAMI BEACH, Fla. & LONG BEACH, Calif.--(BUSINESS WIRE)--The HydraFacial® Company (“HydraFacial,” or the “Company”), a category-creating beauty health company, today announced preliminary net sales for the fiscal year ended December 31, 2020. HydraFacial currently expects net sales for fiscal year 2020 to approximate $119 million. The Company’s previous expectation for net sales, provided on December 9, 2020, was approximately $115 million. The Company has not yet completed the year-end audit and expects to report full results for fiscal year 2020 at a future date. The previously announced business combination with Vesper Healthcare (NASDAQ: VSPR) remains on track to be completed

    2/22/21 6:45:00 AM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson initiated coverage on Vesper Healthcare Acquisition Corp. with a new price target

    DA Davidson initiated coverage of Vesper Healthcare Acquisition Corp. with a rating of Buy and set a new price target of $15.50

    4/13/21 6:59:11 AM ET
    $VSPR
    Business Services
    Finance

    The Benchmark Company initiated coverage on Vesper Healthcare Acquisition Corp. with a new price target

    The Benchmark Company initiated coverage of Vesper Healthcare Acquisition Corp. with a rating of Buy and set a new price target of $16.00

    3/18/21 7:41:55 AM ET
    $VSPR
    Business Services
    Finance

    Benchmark initiated coverage on Vesper Healthcare with a new price target

    Benchmark initiated coverage of Vesper Healthcare with a rating of Buy and set a new price target of $16.00

    3/18/21 6:57:43 AM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    SEC Filings

    View All

    SEC Form 4 filed by Vesper Healthcare Acquisition Corp.

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 8:00:45 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by Vesper Healthcare Acquisition Corp.

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 7:59:07 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 8-K filed by Vesper Healthcare Acquisition Corp.

    8-K - Beauty Health Co (0001818093) (Filer)

    5/20/21 4:07:22 PM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Woo Liyuan

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 8:00:17 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by LCP Edge Holdco LLC

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 4:34:28 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by SAUNDERS BRENT L

    4 - Beauty Health Co (0001818093) (Issuer)

    5/18/21 9:22:28 PM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Vesper Healthcare Acquisition Corp. (Amendment)

    SC 13D/A - Beauty Health Co (0001818093) (Subject)

    5/21/21 4:30:37 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form SC 13D filed by Vesper Healthcare Acquisition Corp.

    SC 13D - Beauty Health Co (0001818093) (Subject)

    5/14/21 4:23:32 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form SC 13G filed

    SC 13G - Vesper Healthcare Acquisition Corp. (0001818093) (Subject)

    2/16/21 3:58:03 PM ET
    $VSPR
    Business Services
    Finance